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Summary
In the presence of unattached/weakly attached kineto-
chores, the spindle assembly checkpoint (SAC) delays
exit from mitosis by preventing the anaphase-promot-
ing complex (APC)-mediated proteolysis of cyclin B,
a regulatory subunit of cyclin-dependent kinase 1
(Cdk1). Like all checkpoints, the SAC does not arrest
cells permanently, and escape from mitosis in the
presence of an unsatisfied SAC requires that cyclin
B/Cdk1 activity be inhibited. In yeast [1–5], and likely
Drosophila [6–8], this occurs through an ‘‘adaptation’’
process involving an inhibitory phosphorylation on
Cdk1 and/or activation of a cyclin-dependent kinase
inhibitor (Cdki). The mechanism that allows vertebrate
cells to escape mitosis when the SAC cannot be satis-
fied is unknown. To explore this issue, we conducted
fluorescence microscopy studies on rat kangaroo
(PtK) and human (RPE1) cells dividing in the presence
of nocodazole. We find that in the absence of micro-
tubules (MTs), escape frommitosis occurs in the pres-
ence of an active SAC and requires cyclin B destruc-
tion. We also find that cyclin B is progressively
destroyed during the block by a proteasome-depen-
dent mechanism. Thus, vertebrate cells do not adapt
to the SAC. Rather, our data suggest that in normal
cells, the SAC cannot prevent a slow but continuous
degradation of cyclin B that ultimately drives the cell
out of mitosis.
Results and Discussion
At 37ºC, the duration of mitosis in PtK1 cells (2N = 11),
defined from nuclear envelope breakdown to nuclear
envelope reformation, is 336 7 min (n = 23). When PtK1
cells enter mitosis in the presence of 400 nM nocoda-
zole, they form a monopolar spindle (Figure 1A) and
remain in mitosis for 191 6 52 min (n = 22). When PtK1
enter mitosis in 10 mM nocodazole, no spindle MTs are
formed (Figure 1B) and they remain in mitosis for 287 6
79 min (n = 38), after which they enter the next G1 in
the presence of 22 unattached kinetochores. Similarly,
although RPE1 (2N = 46) cells normally complete mitosis
*Correspondence: rieder@wadsworth.orgin 17 6 6 min at 37ºC (n = 22), they require 546 6 96 min
(n = 18) in the presence of 200 nM nocodazole and 8756
130 min (n = 13) in the presence of 3.2 mM nocodazole.
As with PtK1 cells, RPE1 cells form rudimentary spindles
at the lower (200 nM) but not at the higher (3.2 mM) drug
concentration (Figures 1C and 1D). When the duration of
mitosis in the presence or absence of MTs is compared
for each cell type, by means of the two-tailed Student’s
t test, they are found to be statistically different with
p values below the 0.0001 level.
As both cell types escape mitosis in the absence of
MTs, they begin to violently bleb and thereafter reflatten
with multiple micronuclei (e.g., see Figures 2B, 2C, and
2E). These findings are consistent with previous reports
that PtK1 and RPE1 cells can exit mitosis without satis-
fying the SAC and also that the duration of the delay is
related to the drug concentration (reviewed in [6]).
Bypassing an Unsatisfied SAC Requires
Cyclin B Degradation
If escaping an unsatisfied SAC involves a Cdki or an in-
hibitory phosphorylation on cyclin B/Cdk1, then early G1
cells produced by this process should contain high cy-
clin B levels. To test this, we followed RPE1 cells in the
presence of 200 nM nocodazole, fixed them shortly after
they had exited mitosis, and stained them for the indi-
rect immunofluorescence (IMF) localization of cyclin B.
When compared to G2 controls in the same cultures,
cells that had escaped mitosis and entered early G1
without satisfying the SAC appeared depleted of cyclin
B (see Figure S1 in the Supplemental Data available
with this article online). To confirm this qualitative find-
ing, we transfected RPE1 cells with a cyclin B-GFP plas-
mid and followed them, in the presence of 200 nM (n = 5)
or 3.2 mM (n = 3) nocodazole, as they escaped mitosis.
Under both conditions, and in all cases, cyclin B fluores-
cence slowly decayed during the block until it was no
longer detectable by eye, after which the cells exited
mitosis (Figures 2A–2C). This decay occurred more
rapidly in cells treated with 200 nM nocodazole than
with 3.2 mM nocodazole (Figure 3). Clute and Pines [9]
reported a similar progressive decay in GFP-cyclin B
fluorescence intensity when HeLa cells were delayed
in mitosis by 10 mM taxol, a drug that stabilizes MTs. In
our study, as in theirs, the fluorescence decay was not
due to photobleaching, since the fluorescence intensity
of GFP-cyclin B containing bystander cells in the same
fields did not change (Figure 3). Thus, in vertebrates,
escape from mitosis when the SAC cannot be satisfied
correlates with the progressive destruction of cyclin B.
Bypassing a Functional SAC Does Not Involve
Adaptation to the Checkpoint
Our finding that cyclin B is destroyed as vertebrate cells
bypass a functional SAC implies that escaping mitosis
requires cyclin B destruction rather than activation of a
Cdki or an inhibitory phosphorylation on cyclin B/Cdk1.
However, it is possible that these other escape routes
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1195Figure 1. Abnormal Spindles with Mad2-
Positive Kinetochores Form in the Presence
of Nocodazole
PtK1 (A, B) and RPE1 (C, D) cultures were in-
cubated with 400 nM (A), 10 mM (B), 200 nM
(C), or 3.2 mM nocodazole for 6 hr (A and B),
9 hr (C), or 15 hr (D), respectively, prior to
fixation and immunostaining for Mad2 and
a-tubulin. First column, DNA; second column,
Mad2; third column, a-tubulin; fourth column,
merged images. Note that a rudimentary
spindle forms in both cell types at the lower
but not higher nocodazole concentrations.
See text for details. Scale bar equals 5 mm.are present but masked by cyclin B destruction. To
test this possibility, we followed RPE1 and PtK1 cells
as they entered mitosis in the presence of nocodazole
and MG132, a potent proteasome inhibitor. Under this
condition, both RPE1 (n = 7) and PtK1 (n = 9) cells failed
to exit mitosis and ultimately died in division after a pro-
longed (>12–15 hr) arrest (Figure S2). To determine
whether the failure of cells treated with both nocodazole
and MG132 to escape mitosis is due to toxic effects
caused by inhibiting proteolysis, we transfected RPE1
cultures with GFP-cyclin B-D85. This cyclin lacks the
N-terminal D-box required for APC-mediated proteoly-
sis [10], yet it binds to Cdk1 and forms an active kinase
complex [11]. We then followed GFP-cyclin B-D85-
containing cells by phase/fluorescence video LM as
they entered mitosis in the presence of 200 nM nocoda-
zole. Not surprisingly, we found that cells expressing
nondegradable cyclin B invariably remained in mitosis
for >24 hr (Figures 2D and 3), whereas neighboring cells
that were not expressing the GFP construct exited mito-
sis within 8–10 hr (Figure 2E). Thus, in vertebrates,
bypassing an unsatisfied SAC requires cyclin B destruc-
tion, and in these cells, other upstream proteolysis-
independent ‘‘adaptation’’ pathways are not operative.
Mad2 and BubR1 Remain Associated with
Kinetochores as Cells Bypass a Functional SAC
Cells could escape mitosis without satisfying the SAC if
kinetochores became progressively modified over time,
until they no longer bound one or more kinetochore-
associated checkpoint-signaling proteins (like Mad2or BubR1), or if one or more of these checkpoint proteins
is degraded during the block. To evaluate this idea, we
asked whether escape from mitosis in the presence of
nocodazole correlates with the disappearance of one
or more SAC proteins from kinetochores, as occurs
during a normal mitosis. To this end, we followed noco-
dazole-treated YFP-Mad2-expressing PtK2 cells as they
entered and exited mitosis. As expected, in control
cells Mad2 fluorescence was not detected on kineto-
chores just prior to anaphase (n = 14; data not shown).
In contrast, we always found a variable number of Mad2-
positive kinetochores in PtK2 cells (n = 17) as they exited
mitosis in the presence of 10 mM nocodazole (Figure S3).
To expand this finding, we treated RPE1 cultures with
200 nM or 3.2 mM nocodazole for 9 or 15 hr, respectively,
to ensure the presence in each of a cell population that
had overridden the SAC. After fixation, the cultures
were then stained with antibodies against SAC proteins
(BubR1, Mad1, and Mad2). Under both conditions, we
invariably found a dot-like staining pattern associated
with the chromatin in cells that had escaped mitosis,
as judged by the presence of decondensing chromo-
somes and/or micronuclei (Figures 4A and 4B). When
compared to cells treated with 200 nM nocodazole,
the kinetochore regions of cells that had escaped mito-
sis in the presence of 3.2 mM nocodazole stained very
intensely for all checkpoint proteins (cf. Figures 4A
and 4B). This difference can be attributed to the fact
that the formation of rudimentary spindles and kineto-
chore fibers at the lower drug concentration (Fig-
ure 1C) depletes checkpoint proteins from some of the
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1196Figure 2. Cyclin B Degradation Is Required for RPE1 Cells to Exit Mitosis in the Presence of an Unsatisfied SAC
Selected phase-contrast (top) and fluorescence (bottom) frames from time-lapse video recordings.
(A–C) RPE1 cells were transfected with a cyclin B-GFP plasmid and GFP-expressing cells were followed.
(A) Non-drug-treated control cell in which cyclin B-GFP accumulates in the nucleus during prophase (25 min) and is then destroyed after the SAC
is satisfied and the cell enters anaphase (15–17 min). Insets show centrosomes at a higher magnification. Time, relative to nuclear envelope
breakdown, is shown in minutes. Scale bar equals 5 mm.
(B and C) GFP-expressing mitotic cells in the presence of 200 nM (B) or 3.2 mM (C) nocodazole. The arrow in each frame marks the cell of interest.
Time is shown in minutes. Note that the cyclin B-GFP fluorescence begins to visibly decline throughout the block and is barely detectable near
the time the cells finally begin to exit mitosis (360 min in [B] and 860 min in [C]).
(D and E) RPE1 cultures were transfected with a GFP-cyclin B-D85 plasmid. 24 hr after transfection, the cultures were incubated with 200 nM
nocodazole and areas were subsequently followed by dual-mode time-lapse microscopy. In the same field of view, we could find GFP-express-
ing and nonexpressing cells.
(D) GFP-expressing cells (e.g., arrow) remained in mitosis until filming was terminated after more than 24 hr, and throughout this time the GFP
fluorescence remained relatively level (see Figure 3).
(E) In contrast, cells in the same culture that were not transfected with the plasmid (e.g., arrows) escaped mitosis afterw8 hr. See also Figure 3.kinetochores. Thus, in vertebrates, exit from mitosis
when the SAC cannot be satisfied is not due to global
changes in kinetochores and/or the destruction of SAC
proteins.
When spindle MT formation is prevented, sister chro-
matids in some but not all vertebrate cells disjoin just
before the cell escapes mitosis [12]. Although this istrue for PtK1 cells [13], our data imply that it does not oc-
cur in RPE1 cells. This is suggested from the fact that
many of the sister kinetochores contained in the restitu-
tion nuclei formed in cells treated with 3.2 mM nocoda-
zole appeared closely linked through a single centro-
mere region (Figure 4B). Since chromatid disjunction
normally occurs via the APCCdc20-mediated destruction
Bypassing the Spindle Assembly Checkpoint
1197Figure 3. Cyclin B Proteolysis Occurs throughout a Nocodazole-Induced Block in Mitosis
RPE1 cultures were transfected with a plasmid carrying either a degradable or nondegradable (D85) GFP-cyclin B, and progress through mitosis
was followed in GFP-expressing cells. Red line, GFP-cyclin B-expressing control cell not treated with nocodazole; orange line, the GFP-cyclin B-
expressing cell shown in Figure 2B that was treated with 200 nM nocodazole; green line, the GFP-expressing cell shown in Figure 2C that was
treated with 3.2 mM nocodazole. Areas containing mitotic cells were then followed by dual-mode time-lapse microscopy. Fluorescence was mea-
sured at each time point in a fixed size area of the cell corresponding to the mitotic spindle region in mitotic cells or the cytoplasm in interphase
cells. Fluorescence levels of both mitotic and interphase cells were normalized to the background. Fluorescence of the mitotic cells was further
normalized to a transfected interphase bystander cell (black lines) to allow comparison of intensities from independent recordings. The data
shown here are representative of 11 control cells, 5 cells expressing GFP-cyclin B and incubated in 200 nM nocodazole, 3 cells expressing
GFP-cyclin B and incubated in 3.2 mM nocodazole, and 3 cells expressing nondegradable GFP-cyclin B-D85 and incubated with 200 nM noco-
dazole (blue line). Note that the higher the nocodazole concentration, the slower cyclin B is degraded and the longer the cells take to exit mitosis
(cf. orange and green lines). Also, degradation of the GFP fluorescence associated with the nondegradable form of cyclin B (blue line) was largely
inhibited. Cells transfected with this construct were unable to escape mitosis during the recording interval (up to 1740 min).of securin, this finding suggests that APCCdc20 is inac-
tive as RPE1 cells exit mitosis without forming MTs.
Tpx2, a MT-associated protein required for spindle
formation, is a conspicuous component of S, G2, and
mitotic, but not G1, cells. Like cyclin B, the level ofTpx2 peaks during spindle formation and then rapidly
declines during anaphase/telophase until it is gone in
early G1 [14]. It was recently shown that Tpx2 degrada-
tion is controlled by APCCdh1, which, unlike APCCdc20,
does not normally become active until anaphase [15].Figure 4. BubR1, Mad1, and Mad2 Remain Associated with RPE1 Kinetochores as Cells Exit Mitosis in the Presence of an Unsatisfied SAC
RPE1 cultures were incubated with 200 nM (A) or 3.2 mM (B) nocodazole for 9 or 15 hr, respectively, before fixation and immunostaining for BubR1
(top), Mad1 (middle), or Mad2 (bottom). Cells that had just exited mitosis (see text for details) were then located and photographed. Left columns
in each panel, DNA; middle columns, BubR1, Mad1, or Mad2; right columns, merged images. Scale bar equals 5 mm.
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1198Figure 5. Tpx2, an APC Substrate, Is Not Degraded in Cells that Exit Mitosis without Satisfying the SAC
(A) In untreated RPE1 cells, Tpx2 (bottom) is found in S/G2 but not G1 nuclei. During mitosis, this MT-associated protein localizes to spindle MTs,
while during anaphase it is found on midbody MTs and centrosomes. Tpx2 is largely degraded by the time the nuclear envelope reforms around
daughter nuclei during late telophase, although some remains associated with the centrosomes (far right row).
(B) After treatment with 3.2 mM nocodazole, Tpx2 (bottom row) is found in the nuclei of G2 and prophase cells. In the absence of spindle MT
formation, this protein then remains diffuse in the cytoplasm throughout the prolonged mitosis. However, once the cells exit mitosis and reflatten
on the substrate (last three images in each row), it is found concentrated in the G1 micronuclei. Top row, merged images; middle row, DNA;
bottom row, Tpx2. Scale bar equals 5 mm.We therefore asked whether Tpx2 is degraded in cells
that have exited mitosis without satisfying the SAC.
For this study, we treated RPE1 cultures with 3.2 mM no-
codazole for 15 hr and fixed and stained them for Tpx2
immunofluorescence. As expected, we found intense
Tpx2 staining in mitotic cells (Figure 5A). However, un-
like in early G1 cells in nontreated control cultures that
are largely depleted of Tpx2 (Figure 5A), high levels of
this protein were always seen in the micronuclei of cells
that had reflattened after bypassing an unsatisfied SAC
(Figure 5B). This result suggests that when the SAC can-
not be satisfied, APCCdh1 activity remains depressed as
cells exit mitosis.How Vertebrate Cells Bypass a Functional SAC
In the presence of drugs that inhibit MT formation, the
SAC cannot be satisfied, yet many cells ultimately es-
cape mitosis and enter the next G1. Here we show that
this escape is not due to adaptation pathways that sup-
press cyclin B/Cdk1 activity by, e.g., inhibitory phos-
phorylations or activation of a Cdki. Importantly, we
also show that this escape is not due to the depletion
of Mad2 or BubR1, which remain associated with unat-
tached kinetochores as the SAC is bypassed. Instead,
we find that in vertebrates, escaping mitosis when in the
presence of a functional SAC requires proteolysis and,
more specifically, the destruction of cyclin B. As first
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1199reported for treatments that stabilize MTs [9], we also
found that cyclin B levels progressively decline during
a mitotic block induced by drugs that prevent MT
assembly. Thus, the key issue for how a vertebrate cell
escapes mitosis when it cannot satisfy the SAC is how
it degrades its cyclin B during the block.
Several recent reports suggest that the checkpoint
proteins Bub1 and BubR1 are degraded in HeLa in a cas-
pase-dependent manner during a mitosis prolonged by
drugs [16–18]. This, by itself, would lead to checkpoint
inactivation, APC-mediated cyclin B destruction, and
escape from mitosis. However, these claims are not
supported by our data that BubR1 remains associated
with kinetochores even after cells have escaped the
mitotic block (Figure 4). Moreover, they are based on
sorting analyses of cell populations, arrested in mitosis
for 24–48 hr, in which the cells are likely dying during
mitosis via apoptosis [19, 20]. Instead, our data appear
to rule out the possibility that vertebrates escape mito-
sis in the absence of MTs by suddenly inactivating the
SAC and thus activating the APCs near the end of
the block. Indeed, when the SAC cannot be satisfied,
the levels of cyclin B decline gradually and not suddenly.
Furthermore, during and after escaping mitosis in the
absence of MTs, the kinetochores retain high levels of
checkpoint signaling proteins (e.g., Mad2 and BubR1),
the APC substrate Tpx2 is not degraded, and RPE1 cells
do not appear to disjoin their chromatids. Concerning
the last point, it is noteworthy that in vertebrates chro-
matid disjunction does not occur even in untreated cells
containing a fully functional spindle until w95% of the
cyclin B has been degraded [9, 11]. Moreover, evidence
is accumulating that this event requires cyclin B destruc-
tion since it does not occur, or is considerably delayed,
in non-drug-treated cells expressing a nondegradable
cyclin B that have presumably satisfied the SAC [11, 21].
In lieu of checkpoint inactivation, there are two non-
mutually exclusive mechanisms for how cells can es-
cape mitosis in the presence of a functional SAC. The
first is that cyclin B is slowly and constantly degraded
in an APC-independent manner until it falls below the
threshold for maintaining the mitotic state. For several
reasons this scenario is highly unlikely. First, our data re-
veal that the degradation of cyclin B is specific to mito-
sis, since it is not seen in G2 GFP-cyclin B-expressing
bystander cells. Second, the degradation of GFP-cyclin
B lacking a D-box, and therefore its APC recognition
site, occurs extremely slowly even in the presence of
fully functional spindles (Figure 3; [9, 11]). Presumably,
in the absence of MTs, any general cyclin denatur-
ation/degradation pathway not involving APCs would
also degrade GFP-cyclin B-D85 at the same rate as de-
gradable cyclin. We evaluated this idea by treating RPE1
cells expressing GFP-cyclin B with 200 nM nocodazole
and 5 mM MG132, and then by asking how quickly
GFP-cyclin B is degraded in the absence of proteasome
function. Although this combination of drugs is lethal
over prolonged periods (12–15 hr; see Figure S2),
we found that the GFP-cyclin B fluorescence intensity
did not decay (and actually slowly increased) over the
5–10 hr we followed the cells (Figure S4). Thus, when
the SAC cannot be satisfied, cyclin B degradation is
not due to a steady general denaturation of the protein
but instead requires proteasome-mediated proteolysis.Finally, we found that cells that form rudimentary spin-
dles in nocodazole escape mitosis significantly faster
than those that cannot generate spindle MTs (Figure 3;
[6, 22]). This positive correlation between the presence
of spindle MTs and an accelerated escape from mitosis
is difficult to explain by a nonspecific cyclin B destruc-
tion mechanism.
The more attractive mechanism for how cells exit mito-
sis in the presence of a functional SAC is simply that the
SAC is not normally 100% effective at blocking all APCs
from ubiquinating cyclin B. Under this condition, a con-
stant low level of ubiquination and subsequent proteoly-
sis would gradually drop the cyclin B level below that
needed to maintain the mitotic state. This route provides
a simple and elegant mechanism for ultimately overcom-
ing the mitotic condition before the cell dies, which, at
least under some conditions, may be important (e.g.,
although the value of this feature to multicellular organ-
isms is not readily apparent, in plants it leads to changes
in ploidy levels and new strains of commercially valuable
crops). This mechanism also provides a straightforward
explanation for why the nocodazole-induced mitotic de-
lay seen in normal [23, 24] and some cancer [25–27] cells
containing abnormally low levels of Mad2 or BubR1 is
greatly attenuated relative to cells containing normal
levels of these checkpoint proteins: since even with nor-
mal Mad2 or BubR1 concentrations the SAC cannot pro-
hibit a low level ubiquination of cyclin B by the APCCdc20
complex, lowering the concentration further makes the
SAC even less effective at inhibiting the APCs, and the
more rapidly cyclin B levels would be degraded below
that needed to maintain the mitotic state.
Cells that form rudimentary spindles in response to
low nocodazole concentrations are unable to satisfy
the SAC as evidenced by the continuous presence of
Mad2 and BubR1 on some kinetochores after they
escape mitosis (Figure 4A). However, as noted above,
such cells exit mitosis significantly faster than those
that cannot generate spindle MTs (see also [6, 22, 28]).
Not surprisingly, we find that nocodazole-treated cells
containing rudimentary spindles degrade their cyclin B
much faster than cells lacking MTs (Figure 3). This means
that when the SAC cannot be satisfied, the mere pres-
ence of MTs somehow accelerates the destruction of
cyclin B. Although the reasons for this are unknown, it
is possible that APCs, which are normally associated
with the spindle [29, 30], work more efficiently when
attached to MTs. Alternatively, at the lower drug concen-
trations, many kinetochores become attached to spindle
MTs, which makes them poor checkpoint signalers be-
cause they possess reduced amounts of checkpoint
proteins (e.g., cf. Figures 1A and 1C with 1B and 1D;
Figures 4A and 4B; see [31]). Under this condition, the
amount of the APC inhibitor ultimately generated may
be significantly less than that formed in the complete
absence of all MTs, and the higher residual APC activity
would produce a more rapid degradation of cyclin B and
a corresponding shorter delay in mitosis.
Supplemental Data
Supplemental Data include four figures and Supplemental Experi-
mental Procedures and can be found with this article online
at http://www.current-biology.com/cgi/content/full/16/12/1194/
DC1/.
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